Highlights Hunan Jingfeng Pharmaceutical Co.,Ltd.

Equities

000908

CNE000000Y11

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
1.39 ^CNY	-4.79%		-22.78%	-57.10%

May. 31	Hunan Jingfeng Pharmaceutical Co.,Ltd. Approves Nomination of Zhang Li as Non-Independent Director	CI
Apr. 29	Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-27	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-30	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Beijing Zhouyu Energy Technology Co., Ltd. completed the acquisition of a 5% stake in Hunan Jingfeng Pharmaceutical Co.,Ltd. from Ye Xiangwu, Ye Gaojing, and Ye Xianglun.	22-03-02	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-27	CI
Beijing Zhouyu Energy Technology Co., Ltd. signed the share transfer agreement to acquire a 5% stake in Hunan Jingfeng Pharmaceutical Co.,Ltd. from Ye Xiangwu, Ye Gaojing, and Ye Xianglun for approximately CNY 220 million.	21-10-11	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-29	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-29	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-29	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-29	CI
Hangzhou Fuyue Yize Equity Investment Partnership Enterprise (Limited Partnership) completed the acquisition of a 20% stake in Wisdom Pharmaceutical Co., Ltd. from Hunan Jingfeng Pharmaceutical Co.,Ltd..	20-10-15	CI
Hangzhou Fuyue Yize Equity Investment Partnership Enterprise (Limited Partnership) signed a share transfer agreement to acquire a 20% stake in Wisdom Pharmaceutical Co., Ltd. from Hunan Jingfeng Pharmaceutical Co.,Ltd. for approximately CNY 160 million.	20-09-11	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-27	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-29	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Hunan Jingfeng Pharmaceutical Co.,Ltd.

Equities

000908

CNE000000Y11

Highlights

Filters